All Relations between Schizophrenia and Amisulpride

Publication Sentence Publish Date Extraction Date Species
Jie Wu, Angela Th Kwan, Taeho Greg Rhee, Roger Ho, Giacomo d'Andrea, Giovanni Martinotti, Kayla M Teopiz, Felicia Ceban, Roger S McIntyr. A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophrenia. Expert review of clinical pharmacology. 2023-10-21. PMID:37864424. a narrative review of non-racemic amisulpride (sep-4199) for treatment of depressive symptoms in bipolar disorder and lb-102 for treatment of schizophrenia. 2023-10-21 2023-11-08 Not clear
Anning Li, Wen Yao Mak, Tingyi Ruan, Fang Dong, Nan Zheng, Meng Gu, Wei Guo, Jingye Zhang, Haoxuan Cheng, Canjun Ruan, Yufei Shi, Yannan Zang, Xuequan Zhu, Qingfeng He, Xiaoqiang Xiang, Gang Wang, Xiao Zh. Population pharmacokinetics of Amisulpride in Chinese patients with schizophrenia with external validation: the impact of renal function. Frontiers in pharmacology. vol 14. 2023-09-21. PMID:37731733. population pharmacokinetics of amisulpride in chinese patients with schizophrenia with external validation: the impact of renal function. 2023-09-21 2023-10-07 Not clear
Jin-Ling Liu, Zhi-Mei Tan, Shu-Jie Jia. Repetitive transcranial magnetic stimulation combined with olanzapine and amisulpride for treatment-refractory schizophrenia. World journal of psychiatry. vol 13. issue 7. 2023-08-07. PMID:37547736. repetitive transcranial magnetic stimulation combined with olanzapine and amisulpride for treatment-refractory schizophrenia. 2023-08-07 2023-08-14 Not clear
Jing Ding, Liu Yang, Xiaohua Cui, Luyao Li, Jiarui Liu, Hongrui Sun, Ting Wang, Yan Zhan. A 5-year retrospective study of amisulpride steady-state plasma concentration in patients with schizophrenia in real-life settings based on therapeutic drug monitoring data. Asian journal of psychiatry. vol 87. 2023-07-23. PMID:37481912. a 5-year retrospective study of amisulpride steady-state plasma concentration in patients with schizophrenia in real-life settings based on therapeutic drug monitoring data. 2023-07-23 2023-08-14 Not clear
Eirik Kjelby, Rolf Gjestad, Farivar Fathian, Igne Sinkeviciute, Renata Alisauskiene, Liss Anda, Else-Marie Løberg, Solveig Klæbo Reitan, Inge Joa, Tor Ketil Larsen, Maria Rettenbacher, Jan Øystein Berle, Ole Bernt Fasmer, Rune Andreas Kroken, Erik Johnse. Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders: A Secondary Outcome Analysis of a Pragmatic, Randomized Trial (BeSt InTro). Journal of clinical psychopharmacology. 2023-04-21. PMID:37083542. consequently, in a 12-month pragmatic, randomized clinical trial, we aimed to investigate differences in antidepressive effectiveness among amisulpride, aripiprazole, and olanzapine as a secondary outcome, measured by change in the calgary depression scale for schizophrenia sum score in patients within the schizophrenia spectrum. 2023-04-21 2023-08-14 Not clear
Wei Liu, Jingqi Zhou, Minjuan Cao, Fangming Zhang, Xiaoming Su. A pharmacokinetic analysis of amisulpride in adult Chinese patients with schizophrenia: Impact of creatinine clearance. International journal of clinical pharmacology and therapeutics. 2023-03-05. PMID:36871243. a pharmacokinetic analysis of amisulpride in adult chinese patients with schizophrenia: impact of creatinine clearance. 2023-03-05 2023-08-14 Not clear
Wei Liu, Jingqi Zhou, Minjuan Cao, Fangming Zhang, Xiaoming Su. A pharmacokinetic analysis of amisulpride in adult Chinese patients with schizophrenia: Impact of creatinine clearance. International journal of clinical pharmacology and therapeutics. 2023-03-05. PMID:36871243. to develop a stable population pharmacokinetic (ppk) model of amisulpride and to investigate the effects of covariates on the pharmacokinetic parameters in adult chinese patients with schizophrenia. 2023-03-05 2023-08-14 Not clear
Shuo Yang, HaiYan Wang, Gao Feng Zheng, Yi Wan. Age, Sex, and Comedication Effects on the Steady-State Plasma Concentrations of Amisulpride in Chinese Patients with Schizophrenia. Therapeutic drug monitoring. 2023-03-02. PMID:36863030. age, sex, and comedication effects on the steady-state plasma concentrations of amisulpride in chinese patients with schizophrenia. 2023-03-02 2023-08-14 Not clear
Shuo Yang, HaiYan Wang, Gao Feng Zheng, Yi Wan. Age, Sex, and Comedication Effects on the Steady-State Plasma Concentrations of Amisulpride in Chinese Patients with Schizophrenia. Therapeutic drug monitoring. 2023-03-02. PMID:36863030. the effects of age, sex, or specific comedications on amisulpride concentrations in chinese patients with schizophrenia in the real world were investigated. 2023-03-02 2023-08-14 Not clear
Ahmed M Abdelfattah, Sally A Abuelezz, Nevien Hendawy, Eman A Negm, Salwa Abd El Khalek Nawishy, Ahmed Mohamed Mohamed Khali. Sonic hedgehog pathway as a new target of atypical antipsychotics: Revisiting of amisulpride and aripiprazole effects in a rat model of schizophrenia. Life sciences. 2023-01-17. PMID:36649751. sonic hedgehog pathway as a new target of atypical antipsychotics: revisiting of amisulpride and aripiprazole effects in a rat model of schizophrenia. 2023-01-17 2023-08-14 rat
Ahmed M Abdelfattah, Sally A Abuelezz, Nevien Hendawy, Eman A Negm, Salwa Abd El Khalek Nawishy, Ahmed Mohamed Mohamed Khali. Sonic hedgehog pathway as a new target of atypical antipsychotics: Revisiting of amisulpride and aripiprazole effects in a rat model of schizophrenia. Life sciences. 2023-01-17. PMID:36649751. in this study, effects of the anti-psychotics amisulpride and/or aripiprazole on the shh-pathway and its relation to cognitive functions and neurogenesis in a rat model of schizophrenia were tested. 2023-01-17 2023-08-14 rat
Ze-Rui Hu, Zhen-Zhen Yang, Xu-Bo Wang, Hong-Shuo Chu, Chuan-Xin Li. Case report: Amisulpride therapy induced reversible elevation of creatine kinase-MB and bradycardia in schizophrenia. Frontiers in psychiatry. vol 13. 2023-01-02. PMID:36590617. case report: amisulpride therapy induced reversible elevation of creatine kinase-mb and bradycardia in schizophrenia. 2023-01-02 2023-08-14 Not clear
Ze-Rui Hu, Zhen-Zhen Yang, Xu-Bo Wang, Hong-Shuo Chu, Chuan-Xin Li. Case report: Amisulpride therapy induced reversible elevation of creatine kinase-MB and bradycardia in schizophrenia. Frontiers in psychiatry. vol 13. 2023-01-02. PMID:36590617. amisulpride, a first-line atypical antipsychotic medication that acts as a blocker of the d2 and d3 dopamine receptors, is used in varying doses for the treatment of both positive and negative symptoms of schizophrenia. 2023-01-02 2023-08-14 Not clear
Computational And Mathematical Methods In Medicin. Retracted: Changes of Mental State and Serum Prolactin Levels in Patients with Schizophrenia and Depression after Receiving the Combination Therapy of Amisulpride and Chloroprothixol Tablets. Computational and mathematical methods in medicine. vol 2022. 2022-12-23. PMID:36561739. retracted: changes of mental state and serum prolactin levels in patients with schizophrenia and depression after receiving the combination therapy of amisulpride and chloroprothixol tablets. 2022-12-23 2023-08-14 Not clear
Lieuwe de Haan, Mirjam van Tricht, Floor van Dijk, Celso Arango, Covadonga M Díaz-Caneja, Julio Bobes, Leticia García-Álvarez, Stefan Leuch. Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders. Psychological medicine. 2022-12-15. PMID:36520136. optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders. 2022-12-15 2023-08-14 Not clear
Correction to "Amisulpride Augmentation of Clozapine in Clozapine-Resistant Schizophrenia: A Case Series". The Canadian journal of hospital pharmacy. vol 75. issue 4. 2022-10-17. PMID:36246449. correction to "amisulpride augmentation of clozapine in clozapine-resistant schizophrenia: a case series". 2022-10-17 2023-08-14 Not clear
Ming-Huan Zhu, Zhen-Jing Liu, Qiong-Yue Hu, Jia-Yu Yang, Ying Jin, Na Zhu, Ying Huang, Dian-Hong Shi, Min-Jia Liu, Hong-Yang Tan, Lei Zhao, Qin-Yu Lv, Zheng-Hui Yi, Feng-Chun Wu, Ze-Zhi L. Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial. Military Medical Research. vol 9. issue 1. 2022-10-17. PMID:36253804. amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial. 2022-10-17 2023-08-14 Not clear
Ming-Huan Zhu, Zhen-Jing Liu, Qiong-Yue Hu, Jia-Yu Yang, Ying Jin, Na Zhu, Ying Huang, Dian-Hong Shi, Min-Jia Liu, Hong-Yang Tan, Lei Zhao, Qin-Yu Lv, Zheng-Hui Yi, Feng-Chun Wu, Ze-Zhi L. Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial. Military Medical Research. vol 9. issue 1. 2022-10-17. PMID:36253804. the main purpose of this randomized, double-blind, placebo-controlled trial was to explore the amisulpride augmentation efficacy on the psychopathological symptoms and cognitive function of clozapine-resistant treatment-refractory schizophrenia (ctrs) patients. 2022-10-17 2023-08-14 Not clear
Young Sup Woo, Sung-Yong Park, Bo-Hyun Yoon, Won-Seok Choi, Sheng-Min Wang, Won-Myong Bah. Amisulpride Augmentation in Schizophrenia Patients with Poor Response to Olanzapine: A 4-week, Randomized, Rater-Blind, Controlled, Pilot Study. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 20. issue 3. 2022-07-25. PMID:35879041. amisulpride augmentation in schizophrenia patients with poor response to olanzapine: a 4-week, randomized, rater-blind, controlled, pilot study. 2022-07-25 2023-08-14 Not clear
Yanqun Zheng, Xiaohua Liu, Mingliang J. A case of antipsychotic-induced psychomotor seizure. General psychiatry. vol 35. issue 3. 2022-07-22. PMID:35866001. the authors present a case of psychomotor seizure caused by amisulpride to treat schizophrenia. 2022-07-22 2023-08-14 Not clear